March 2021

Abbott received approval for the use of its handheld diagnostic blood test that produces results within 15 minutes and can help evaluate patients with suspected mild traumatic brain injuries, including concussions.
Read More

Functional MRI test results suggest that olfactory pathway impairment involving the orbitofrontal cortex may be linked to the negative effects on sense of taste and smell associated with COVID-19 infection.
Read More

The FDA approved a new intramuscular injection route of administration for Plegridy (peginterferon beta-1a) for the treatment of relapsing forms of multiple sclerosis.
Read More

Clinicians and patients should consider the immune-modulating effects of various disease-modifying therapies and their implications for COVID-19 susceptibility and vaccine-generated immune response.
Read More

Researchers report on a case of a patient with severe COVID-19 infection who subsequently developed optic nerve inflammation and demyelinating lesions in the central nervous system.
Read More

Subscribe to
Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to recieve the free VBCN e‑Newsletter.

I'd like to recieve: